medigraphic.com
SPANISH

Revista Cubana de Hematología, Inmunología y Hemoterapia

ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2022; 38 (1)

Microbiological Map - 2020 from Institute of Hematology and Immunology, Cuba

Rodríguez PM, González PJ, Rodríguez MMR, Cuevas DRS
Full text How to cite this article

Language: Spanish
References: 26
Page: 1-16
PDF size: 329.84 Kb.


Key words:

microbiological map, bacterial resistance, epidemiological marker, blood culture.

ABSTRACT

Introduction: Microbiological maps are considered an epidemiological marker as statistically summarize circulating bacteria and their behavior against antibiotics in use. They allow establishing an antibiotic policy that guarantees the most rational use of antimicrobials and decreases the risk of bacterial resistance.
Objectives: Identify the isolated bacteria with more frequency from microbiological crops of hospitalized patients in the Institute of Hematology and Immunology during the year 2020 and determine the resistance of the most frequent bacteria to the antimicrobials tested, with a view to establishing the first microbiological map of the institution.
Methods: An observational, descriptive, cross-sectional study was performed that included cultures of patients hospitalized during the year 2020. Bacterial identification was carried out according to conventional methods and to determine the resistance profiles was used by the Bauer-Kirby method.
Results: The blood culture was the most indicated microbiological study with 32.80% positivity. The Gram negative bacteria predominated (81.71%), being the most identified Pseudomona spp., Enterobacter spp., Klebsiella spp. and Escherichia coli. Among the Gram positive bacteria predominate Staphylococcus spp. coagulase negative. High percentages of resistance were obtained in front of almost all antimicrobials evaluated.
Conclusions: The completion of the institutional microbiological map allows updating the antimicrobial use policy by identifying the Gram negative bacilli, with high percentages of resistance, as the main etiological agents of the infections registered in this health center during 2020.


REFERENCES

  1. Rivas Llamas JR. Neutropenia febril: el punto de vista del hematólogo. Gac Mex Oncol 2016;15(4):212-21. DOI: https://dx.doi.org/10.1016/j.gamo.2016.07.005

  2. Butts AR, Bachmeier CC, Dressler EV, Liu M, Cowden A, Talbert J, et al. Association of time to antibiotics and clinical outcomes in adult hematological malignancy patients with febrile neutropenia. J Oncol Pharm Pract 2017;23(4):278-83. DOI: https://10.1177/1078155216687150

  3. Pérez-Heras I, Raynero-Mellado RC, Díaz-Merchán R, Domínguez-Pinilla N. Neutropenia febril posquimioterapia. Estancia hospitalaria y experiencia en nuestro medio. An Pediatr 2020;92 (3):141-6. DOI: https://10.1016/j.anpedi.2019.05.008

  4. Medina-Morales DA, Machado-Duque ME, Machado-Alba JE. Resistencia a antibióticos, una crisis global. Rev Med Risaralda 2015;21(1):74.

  5. Serra Valdés MA. La resistencia microbiana en el contexto actual y la importancia del conocimiento y aplicación en la política antimicrobiana. Rev Hab Cienc Méd 2017;16(3):402-19.

  6. Limmathurotsakul D, Dunachie S, Fukuda K, Feasey NA, Okeke IN, Holmes AH, et al. Improving the estimation of the global burden of antimicrobial resistant infections. Lancet Infect Dis 2019;19:392-8. DOI: https://dx.doi.org/10.1016/S1473-3099(19)30276-2

  7. Semret M, Haraoui LP. Antimicrobial Resistance in the Tropics. Infect Dis Clin N Am 2019;33:231-45.

  8. WHO. Antimicrobial resistance. 2018. [acceso 20/12/2020]; Disponible en: Disponible en: www.who.int/mediacentre/factsheets/fs194/en/

  9. Fariña N. Resistencia bacteriana: un problema de salud pública mundial de difícil solución. Mem Inst Inves Cien Sal 2016;14(1):4-5.

  10. Quiñones Pérez D. Resistencia antimicrobiana: evolución y perspectivas actuales ante el enfoque "Una salud". Rev Cubana Med Trop 2017;69(3):1-17.

  11. Oliva Martínez MM, Báez Gómez AL. Epidemia silente del siglo XXI. Resistencia microbiana a los antibióticos. Medimay [Internet]. 2019 [acceso 25/01/2021];26(2):233-47. Disponible en: Disponible en: http://www.medimay.sld.cu/index.php/rcmh/article/view/1419

  12. Pérez Faraldo B, González Isla F. Importancia del mapa microbiano para la vigilancia de la resistencia antimicrobiana en los servicios hospitalarios. CCM [Internet]. 2017 Jun [acceso 02/09/2020];21(2):561-4. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812017000200021&lng=es

  13. González Martínez ML, López Novo M, Montesino López M, Pérez Plana Y, Martínez Sánchez H. Resistencia microbiana de microorganismos aislados en neonatología: Hospital "Abel 14. Santamaría Cuadrado" 2015. Rev Cienc Med Pinar del Rio 2016;20(5):593-602.

  14. Thowinson-Hernández MC, Hernández-Martínez A. Neutropenia febril inducida por quimioterapia e infecciones asociadas: una revisión de la literatura. Gac Mex Oncol 2019 Oct-Dec;18(4):333-8. DOI: https://10.24875/j.gamo.19000296

  15. Murray PR, Rosenthal KS, Pfaller MA. Medical microbiology. 8th ed. Canada: Elsevier; 2016. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. CLSI supplement M100. 27ª ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2017. [acceso 25/01/2021]; Disponible en: Disponible en: https://clsi.org/standards/products/microbiology/documents/m100/

  16. Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank HP, Ducomble T, et al. Burden of six healthcare-associated infections on European population health: estimating incidence-based disabilityadjusted life years through a population prevalence-based modelling study. PLoS Med. 2016;13(10):e1002150. DOI: https://10.1371/journal.pmed.1002150

  17. Suetens C, Latour K, Karki T, Ricchizzi E, Kinross P, Moro ML, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two european point prevalence surveys, 2016 to 2017. Euro Surveill. 2018;23(46):pii=1800394. DOI: https://doi.org/10.2807/1560-7917.ES.2018.23.46.1800394

  18. Despotovic A, Milosevic B, Milosevic I, Mitrovic N, Cirkovic A, Jovanovic S, et al. Hospital-acquired infections in the adult intensive care unit-Epidemiology, antimicrobial resistance patterns, and risk factors for acquisition and mortality. Am J Infect Control 2020;48(10):1211−5. DOI: https://10.1016/j.ajic.2020.01.009

  19. Milá-Pascual MdC, Campos-Bestard I, Torres-Milá I, Aties-López L. Hemocultivos de pacientes ingresados en el Hospital Clínico Quirúrgico “Dr. Ambrosio Grillo Portuondo”, Santiago de Cuba. Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta. 2021[acceso 25/01/2021];46(1). Disponible en: Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/2480 .

  20. Maldonado ME, Acuña M, Álvarez AM, Avilés CL, de la Maza V, Salgado C, et al. Microorganismos aislados de hemocultivos en niños con cáncer y neutropenia febril de alto riesgo en cinco hospitales de Santiago, Chile, período 2012-2015. Rev Chilena Infect 2018;35(2):140-6. DOI: https://dx.doi.org/10.4067/s0716-10182018000200140

  21. Garzón JR, Isaza N, Posada A, Méndez R, Arenas J, Ardila MP, et al. Características clínicas y microbiológicas de pacientes con neutropenia febril en un hospital universitario. Infectio 2019;23(4):347-57. DOI: https://dx.doi.org/10.22354/in.v23i4.806

  22. Zafar Iqbal-Mirza S, Estévez-González R, Serrano Romero de Ávila V, De Rafael González E, Heredero-Gálvez E, Julián-Jiménez A. Factores predictivos de bacteriemia en los pacientes atendidos en el servicio de urgencias por infección. Rev Esp Quimioter 2020;33:32-43. DOI: https://10.37201/req/075.2020

  23. Finello M, Suasnabar DF, García MdJ, Díaz MV, Richetta L, Toranzo A, et al. Características clínicas y microbiológicas de infecciones del torrente sanguíneo en pacientes adultos neutropénicos. Rev Argentina Microb [Internet]. 2020 Dic [acceso 25/01/2021]; Disponible en: Disponible en: https://doi.org/10.1016/j.ram.2020.11.001

  24. Mandal PK, Maji SK, Dolai TK, De R, Dutta S, Saha S, et al. Micro-organisms Associated with Febrile Neutropenia in Patients with Haematological Malignancies in a Tertiary Care Hospital in Eastern India. Indian J Hematol Blood Transfus 2015;31(1):46-50. DOI: https://10.1007/s12288-014-0393-1

  25. Paz-Montes A, Fuenmayor-Boscán A, Sandrea-Toledo L, Piña-Reyes E, López-Dávila M, et al. Incidencia de microorganismos en hemocultivos procesados en un hospital del estado Zulia y su resistencia a los agentes antimicrobianos. Kasmera [revista en internet]. 2015 [acceso 20/12/2020];43(1):16-33. Disponible en: Disponible en: https://pdfs.semanticscholar.org/d6f9/3f65a2c6fa72cd06e81b51d3e532a70fd0f9.pdf .

  26. Cataño-Toro D, Marìn Medina DS, Rivera J, Martínez JW, Sánchez-Duque J, Martínez-Muñoz M, et al. Neutropenia febril en pacientes con neoplasias hematológicas de un centro de referencia en Colombia: características clínicas y desenlaces. SU [Internet]. 13 de junio de 2019 [acceso 02/09/2020];35(2). Disponible en: Disponible en: https://rcientificas.uninorte.edu.co/index.php/salud/article/view/11896




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Hematol Inmunol Hemoter . 2022;38